• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell: Early-warning Signals and the Role of H9N2 in the Spillover of Avian Influenza Viruses

Michael Coston

Editor, Senior Moderator
Cell: Early-warning Signals and the Role of H9N2 in the Spillover of Avian Influenza Viruses




#18,394

While H9N2 may not be at the very top of our pandemic threats list, this LPAI virus is viewed by many as an important and influential player in the avian flu world.
While H9N2 is not considered a `reportable' disease by WOAH (formerly the OIE), the CDC has 2 different lineages (A(H9N2) G1 and A(H9N2) Y280) on their short list of influenza viruses with pandemic potential (see CDC IRAT SCORE), and several candidate vaccines have been developed.

But H9N2's biggest threat may come its ability to reassort with other, potentially more virulent, subtypes.

w400-h220


Its internal genes have often been found inside many HPAI viruses (including H5N1, H5N6, H7N9, and most recently zoonotic H3N8) - (see last January's Transboundary & Emerging Dis.: The H5N6 Virus Containing Internal Genes From H9N2 Exhibits Enhanced Pathogenicity and Transmissibility).

H9N2 is such a versatile virus, it has even been detected in Egyptian Fruit bats (see Preprint: The Bat-borne Influenza A Virus H9N2 Exhibits a Set of Unexpected Pre-pandemic Features).​

Seven years ago, inEID Journal: Two H9N2 Studies Of Note, we looked at two reports which warned that H9N2 continues to evolve away from current (pre-pandemic and poultry) vaccines and is potentially on a path towards better adaptation to human hosts.


All of which serves as prelude to an article, published this week in Cell, which examines H9N2's role in facilitating the spillover of avian flu viruses to humans. This is a lengthy, and detailed report, and I've only posted some brief excerpts.

Follow the link to read it in its entirety. I'll have a bit more after the break.
Yan-He Wang1,2,12 ∙ Jin-Jin Chen1,3,12 ∙ Jun Ma1,4,12∙ … ∙ Yan-Song Sun1 sunys6443@126.comWei Liu1,7 liuwei@bmi.ac.cnLi-Qun Fang1,4,7,13 fang_lq@163.com… Show more Context and significance

Highlights

Wang et al. provided valuable insights into the epidemiological patterns of avian influenza virus (AIV) spillover and the role of H9N2 in the process. Their analysis highlighted the significant contribution of the internal genes (INGEs) from 12 key strains of H9N2 in facilitating human adaptability by reducing the species barrier between poultry and humans, essentially acting as internal genetic donors for AIV spillover.

Due to its low pathogenicity, H9N2 has been neglected in poultry vaccination programs, leading to a lack of vaccines specifically targeting the INGEs of these 12 key strains. Their findings suggest that reducing the prevalence of H9N2 is fundamental to mitigating AIV spillover risks.

• H9N2 exerts a promoting effect on the spillover of avian influenza viruses (AIVs)
• Expansion of AIV spatial and host ranges reveals an emerging risk of its spillover
• Prevalence of AIVs in human-contacted hosts reveals a re-emergence risk in humans

Summary

Background

The spillover of avian influenza viruses (AIVs) presents a significant global public health threat, leading to unpredictable and recurring pandemics. Current pandemic assessment tools suffer from deficiencies in terms of timeliness, capability for automation, and ability to generate risk estimates for multiple subtypes in the absence of documented human cases.

Methods

To address these challenges, we created an integrated database encompassing global AIV-related data from 1981 to 2022. This database enabled us to estimate the rapid expansion of spatial range and host diversity for specific AIV subtypes, alongside their increasing prevalence in hosts that have close contact with humans. These factors were used as early-warning signals for potential AIV spillover. We analyzed spillover patterns of AIVs using machine learning models, spatial Durbin models, and phylogenetic analysis.

Findings

Our results indicate a high potential for future spillover by subtypes H3N1, H4N6, H5N2, H5N3, H6N2, and H11N9. Additionally, we identified a significant risk for re-emergence by subtypes H5N1, H5N6, H5N8, and H9N2. Furthermore, our analysis highlighted 12 key strains of H9N2 as internal genetic donors for human adaptation in AIVs, demonstrating the crucial role of H9N2 in facilitating AIV spillover.

Conclusions

These findings provide a foundation for rapidly identifying high-risk subtypes, thus optimizing resource allocation in vaccine manufacture. They also underscore the potential significance of reducing the prevalence of H9N2 as a complementary strategy to mitigate chances of AIV spillovers.

(SNIP)

The H9N2 virus has been prevalent in poultry for an extended period. Despite its low pathogenicity and case fatality rate,
10,34 our data show that it plays a crucial role in the spillover of AIVs within local and surrounding areas.

Moreover, H9N2 viruses contributed to recombination events involving eight AIV subtypes that recently spilled over into humans by providing their six INGEs to these viruses. This suggests that H9N2 facilitates the generation of human adaptivity by reducing the species barrier between poultry and humans.57,58

These findings highlight that reducing the prevalence of H9N2 could potentially mitigate the spillover of AIVs, serving as an alternative strategy for preventing individual subtypes such as H5N1, H5N6, and H7N9.

(Continue . . . )

While undoubtedly much older, LPAI H9N2 was first identified in Wisconsin poultry in 1966. In the 1990s it swept across much of Eurasia, becoming `hyperendemic' in many affected countries (see 2019's Viruses: A Global Perspective on H9N2 Avian Influenza Virus). [TABLE="cellpadding: 0, cellspacing: 0"]
[TR]
[TD][/TD]
[/TR]
[TR]
[TD]Range Of Endemic H9N2 Viruses[/TD]
[/TR]
[/TABLE]

While some attempts have been made at controlling the virus (including using largely ineffective vaccines) - since H9N2 produces relatively mild illness in poultry - it is often tolerated or ignored.

Over the past 3 decades H9N2 has managed to spread across much of Asia, and into Europe, Africa and the Middle East. It has diverged into two distinct lineages, has increased its ability to infect mammals, and it continues to fuel the emergence and spillover of new subtypes.​

It seems likely that unless and until H9N2 can be better controlled, our avian flu woes may extend far beyond just H5Nx in the years ahead.



https://afludiary.blogspot.com/2025/03/cell-early-warning-signals-and-role-of.html
 
Back
Top Bottom